178 related articles for article (PubMed ID: 19602232)
1. Identification of potential therapeutic targets in human head & neck squamous cell carcinoma.
Han J; Kioi M; Chu WS; Kasperbauer JL; Strome SE; Puri RK
Head Neck Oncol; 2009 Jul; 1():27. PubMed ID: 19602232
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma.
Han J; Fujisawa T; Husain SR; Puri RK
BMC Cancer; 2014 Mar; 14():173. PubMed ID: 24612587
[TBL] [Abstract][Full Text] [Related]
3. Data-Driven prioritisation of antibody-drug conjugate targets in head and neck squamous cell carcinoma.
Hanemaaijer SH; van Gijn SE; Oosting SF; Plaat BEC; Moek KL; Schuuring EM; van der Laan BFAM; Roodenburg JLN; van Vugt MATM; van der Vegt B; Fehrmann RSN
Oral Oncol; 2018 May; 80():33-39. PubMed ID: 29706186
[TBL] [Abstract][Full Text] [Related]
4. CD44 as a stem cell marker in head and neck squamous cell carcinoma.
Faber A; Barth C; Hörmann K; Kassner S; Schultz JD; Sommer U; Stern-Straeter J; Thorn C; Goessler UR
Oncol Rep; 2011 Aug; 26(2):321-6. PubMed ID: 21617876
[TBL] [Abstract][Full Text] [Related]
5. Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma.
Gonzalez HE; Gujrati M; Frederick M; Henderson Y; Arumugam J; Spring PW; Mitsudo K; Kim HW; Clayman GL
Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):754-9. PubMed ID: 12874078
[TBL] [Abstract][Full Text] [Related]
6. CD44(+) tumor cells promote early angiogenesis in head and neck squamous cell carcinoma.
Ludwig N; Szczepanski MJ; Gluszko A; Szafarowski T; Azambuja JH; Dolg L; Gellrich NC; Kampmann A; Whiteside TL; Zimmerer RM
Cancer Lett; 2019 Dec; 467():85-95. PubMed ID: 31593802
[TBL] [Abstract][Full Text] [Related]
7. Distinct epigenetic profiling in head and neck squamous cell carcinoma stem cells.
Furusawa J; Zhang H; Vural E; Stone A; Fukuda S; Oridate N; Fang H; Ye Y; Suen JY; Fan CY
Otolaryngol Head Neck Surg; 2011 Jun; 144(6):900-9. PubMed ID: 21493336
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma.
Bae WJ; Koo BS; Lee SH; Kim JM; Rho YS; Lim JY; Moon JH; Cho JH; Lim YC
Br J Cancer; 2017 Dec; 117(12):1810-1818. PubMed ID: 29096401
[TBL] [Abstract][Full Text] [Related]
9. Silencing heat shock protein 27 decreases metastatic behavior of human head and neck squamous cell cancer cells in vitro.
Zhu Z; Xu X; Yu Y; Graham M; Prince ME; Carey TE; Sun D
Mol Pharm; 2010 Aug; 7(4):1283-90. PubMed ID: 20540527
[TBL] [Abstract][Full Text] [Related]
10. 2D-DIGE proteomic characterization of head and neck squamous cell carcinoma.
Merkley MA; Weinberger PM; Jackson LL; Podolsky RH; Lee JR; Dynan WS
Otolaryngol Head Neck Surg; 2009 Nov; 141(5):626-32. PubMed ID: 19861202
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance.
Liu S; Ren B; Gao H; Liao S; Zhai YX; Li S; Su XJ; Jin P; Stroncek D; Xu Z; Zeng Q; Li Y
J Transl Med; 2017 Sep; 15(1):189. PubMed ID: 28877725
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance.
Athanassiou-Papaefthymiou M; Shkeir O; Kim D; Divi V; Matossian M; Owen JH; Czerwinski MJ; Papagerakis P; McHugh J; Bradford CR; Carey TE; Wolf GT; Prince ME; Papagerakis S
Int J Immunopathol Pharmacol; 2014; 27(3):337-49. PubMed ID: 25280025
[TBL] [Abstract][Full Text] [Related]
13. Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinoma.
van Hal NL; van Dongen GA; Stigter-van Walsum M; Snow GB; Brakenhoff RH
Int J Cancer; 1999 Sep; 82(6):837-45. PubMed ID: 10446451
[TBL] [Abstract][Full Text] [Related]
14. Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target.
Tripathi P; Kamarajan P; Somashekar BS; MacKinnon N; Chinnaiyan AM; Kapila YL; Rajendiran TM; Ramamoorthy A
Int J Biochem Cell Biol; 2012 Nov; 44(11):1852-61. PubMed ID: 22743333
[TBL] [Abstract][Full Text] [Related]
15. Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot.
Yoo GH; Piechocki MP; Ensley JF; Nguyen T; Oliver J; Meng H; Kewson D; Shibuya TY; Lonardo F; Tainsky MA
Clin Cancer Res; 2002 Dec; 8(12):3910-21. PubMed ID: 12473607
[TBL] [Abstract][Full Text] [Related]
16. Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.
Rebelatto MC; Midha A; Mistry A; Sabalos C; Schechter N; Li X; Jin X; Steele KE; Robbins PB; Blake-Haskins JA; Walker J
Diagn Pathol; 2016 Oct; 11(1):95. PubMed ID: 27717372
[TBL] [Abstract][Full Text] [Related]
17. The CD44+/CD24- phenotype is enriched in basal-like breast tumors.
Honeth G; Bendahl PO; Ringnér M; Saal LH; Gruvberger-Saal SK; Lövgren K; Grabau D; Fernö M; Borg A; Hegardt C
Breast Cancer Res; 2008; 10(3):R53. PubMed ID: 18559090
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.
Lo WL; Yu CC; Chiou GY; Chen YW; Huang PI; Chien CS; Tseng LM; Chu PY; Lu KH; Chang KW; Kao SY; Chiou SH
J Pathol; 2011 Mar; 223(4):482-95. PubMed ID: 21294122
[TBL] [Abstract][Full Text] [Related]
19. Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells.
Subramanian C; Kovatch KJ; Sim MW; Wang G; Prince ME; Carey TE; Davis R; Blagg BSJ; Cohen MS
Neoplasia; 2017 Dec; 19(12):1003-1011. PubMed ID: 29121598
[TBL] [Abstract][Full Text] [Related]
20. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
